News for Acerus Pharmaceuticals Corporation (ASPCF)

The Global Testosterone Replacement Therapy Market Size was Valued at USD 1.98 Billion in 2023 and the Worldwide Testosterone Replacement Therapy Market...

/PRNewswire/ -- The

TORONTO, July 10, 2023 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (the “

TORONTO, May 25, 2023 (GLOBE NEWSWIRE) — As announced on January 26, 2023, Acerus Pharmaceuticals Corporation (the “

The Newly Institute Inc. , HEAL Global Holdings Corp. , and Pathway Health Corp. , an integrated healthcare company that provides products and services to patients suffering from chronic pain and... | April 1, 2023

TORONTO, March 14, 2023 (GLOBE NEWSWIRE) -- On January 26, 2023, Acerus Pharmaceuticals Corporation and certain of its subsidiaries (collectively,...

Results from 3 major testosterone trials are expected in 2023. Read more to see why I think AbbVie and ANI are best positioned to benefit from this.

TORONTO, Dec. 22, 2022 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (the “

Read Acerus Pharmaceuticals (TSE:ASP) Stock Price Passes Below Fifty Day Moving Average of $2.35 at ETF Daily News

Read Acerus Pharmaceuticals (TSE:ASP) Stock Price Passes Below Fifty Day Moving Average of $2.64 at ETF Daily News

Read Analyzing Acerus Pharmaceuticals (OTCMKTS:TRLPF) and Kiora Pharmaceuticals (NASDAQ:KPRX) at ETF Daily News